Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03125135 · ClinicalTrials.gov registry record · NA

Accuracy of Noninvasive Pulse Oximeter Sensor (MightySat RX)

A NA study of Healthy, sponsored by Masimo Corporation.

Completed
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT03125135 is a NA study of Healthy that has completed, run by Masimo Corporation. The registered enrollment target is 16 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03125135, a NA study of Healthy, has completed, sponsored by Masimo Corporation.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

In this study, the level of oxygen within the blood will be reduced in a controlled manner by reducing the concentration of oxygen the study volunteer breathes. The accuracy of a noninvasive pulse oximeter sensor will be assessed by comparison to the oxygen saturation measurements from a laboratory blood gas analyzer.

Conditions Studied

Interventions

  • DEVICE MightySat RX Pulse Oximeter Sensor

Study Locations (1)

California

  • Masimo Corporation - Irvine

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2014-11-12
Est. Completion 2014-12-17
Phase NA

Sponsor

Masimo Corporation

96 total trials

What the Registry Record Tells You About NCT03125135

The ClinicalTrials.gov registry entry for NCT03125135 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (98% lower). The listed sponsor is Masimo Corporation, which has 96 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which MightySat RX Pulse Oximeter Sensor is the first listed.

NCT03125135 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03125135 about?

NCT03125135 is a clinical study titled "Accuracy of Noninvasive Pulse Oximeter Sensor (MightySat RX)". In this study, the level of oxygen within the blood will be reduced in a controlled manner by reducing the concentration of oxygen the study volunteer breathes. The accuracy of a noninvasive pulse oximeter sensor will be assessed by comparison to the oxygen saturation measurements from a laboratory ...

What is the current status of trial NCT03125135?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2014-11-12. Estimated completion is 2014-12-17.

What conditions does trial NCT03125135 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT03125135?

The interventions under investigation include: MightySat RX Pulse Oximeter Sensor (DEVICE).

Who is sponsoring clinical trial NCT03125135?

This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03125135 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.